Purdue Pharma Explores Bankruptcy After Thousands of Lawsuits
OxyContin-maker Purdue Pharma LP is exploring bankruptcy to prepare for the thousands of lawsuits filed against the company, Reuters reported early this morning. An official statement has yet to be released by the private pharmaceutical …
Johnson & Johnson Investigation: Shares Fall Again Over Asbestos
Another Johnson & Johnson investigation (NYSE:JNJ) is underway, and JNJ shares have taken a nosedive in response. Once again, the company is being investigated for asbestos contamination.
JNJ shares dived from $136.39 USD …
JNJ Stock: Johnson & Johnson Misses Analyst Target for Forecast 2019 Sales
Johnson & Johnson (JNJ) (NYSE:JNJ) released its forecast 2019 sales earlier today. The pharmaceutical giant fell short of analyst estimates after previously reporting better-than-expected Q4 results. On the news, JNJ stock is down -2.06%, selling …
US Drug Companies Raise Med Prices Despite President Trump Pressure
2019 is not kicking off to a great start for most Americans. US drug companies kicked off the year implementing price increases on more than 250 prescription drugs—despite pressure from President Trump to not do …
Johnson & Johnson Shares Nosedive After New Asbestos Report Surfaces
The Johnson & Johnson (NYSE:JNJ) asbestos saga continues. This morning, Reuters released a “special report” documenting that the manufacturer knew that its most popular product contained asbestos. Due to this report, JNJ shares have plummeted …
Johnson & Johnson Baby Powder Cancer Case Cleared
Johnson & Johnson (NYSE:JNJ) has successfully persuaded a California jury to reject a woman’s claims that asbestos in the company’s well-known baby powder is what caused her to develop cancer. Johnson & Johnson’s baby powder …
CVS Health Launches its Pilot Membership Program in Boston and Its Stock Jumps
CVS Health Corporation (NYSE:CVS), also known as CVS Pharmacy, just announced that customers in the Greater Boston area can enroll in CarePass. CarePass is CVS’s new pilot membership program that adds to its popular ExtraCare …
Pfizer Offers Early Retirement Ahead of Layoffs Next Year
Pfizer Inc. (NYSE:PFE) has been a long-time heavy hitter in the pharmaceutical industry, but it is soon facing layoffs. According to reports by CNBC, Pfizer is offering early retirement to US workers ahead of its …
Teva Pharmaceutical Gaining Momentum After FDA Approves EpiPen
On Thursday, the FDA approved the Teva EpiPen, a move that marks a significant blow to the company’s rival, Mylan N.V.
To no surprise, the market is still riding this high on Friday, …
23andMe Gives Customer Data to GlaxoSmithKlein
23andMe launched a DNA testing service in 2007. Since then, more than 5 million people have used the genomics service to find out about their biological inheritance.
With every application, 23andMe receives information …